| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.057 | 0.3 |